NCT00274703View on ClinicalTrials.gov

An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Oesophagitis, Eosinophilic

Interventions

DRUG

mepolizumab

Trial Locations (1)

4600

GSK Investigational Site, Olten

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY